MENU
IBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ImmunityBio (IBRX) Ownership - Who owns ImmunityBio?

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
691
Web
https://www.immunitybio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.5B
P/E Ratio
N/A
Total Cash
380.88M
Projected Growth
N/A
Total Debt
719.16M
Revenue
140.98M
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
N/A
Revenue/Share
0.15 USD as % of share price
View a ticker or compare two or three
IBRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of cancer treatment products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
691
Web
https://www.immunitybio.com